Campbell Soup ( CPB) price target and estimates were raised at UBS. Soup revenue momentum, said UBS. Price target goes to $48.

Eaton Vance ( EV) numbers were increased at Jefferies through 2014. Company is leveraged to market appreciation and seeing higher fund flows, Jefferies said. Hold rating and new $42 price target.

FedEx ( FDX) estimates, target were reduced at Deutsche Bank. Shares are now seen reaching $125. Estimates were also cut, given lower expected freight demand, Deutsche said. Buy rating.

Liberty Media ( LMCA) numbers were raised at Lazard Capital Markets. Shares are now seen reaching $146. Estimates were also increased, given the addition of equity stakes in Charter ( CHTR) and Sirius XM ( SIRI), Lazard Capital Markets said. Buy rating.

Microsoft ( MSFT) price target was raised at UBS to $40. Better earnings visibility, cloud momentum and core enterprise strength, said UBS.

Priceline.com ( PCLN) numbers were boosted at Cantor Fitzgerald. Shares are now seen reaching $900. Estimates were also increased, following the Kayak acquisition. Buy rating.

Signet Jewelers ( SIG) price target was raised at Citigroup to $76. Continued strong comp store sales driven by proprietary products.

Urban Outfitters ( URBN) numbers boosted at Credit Suisse. Shares are now seen reaching $51. Estimates also upped, given increased productivity, Credit Suisse said. Outperform rating.

Urban Outfitters price target and estimates were reduced at UBS. Estimates were reduced to reflect both lower SG&A and lower gross margin, said UBS. Price target goes to $45.

Urban Outfitters added to Best Ideas List at Janney Capital Markets. Company is seeing higher comp sales growth and cutting operating costs, Janney said. Buy rating and $52 price target.

WisdomTree ( WETF) price target and estimates were raised at Citigroup to reflect updated NAVs and higher volume assumptions, Citigroup said. Price target goes to $16.

Yahoo! ( YHOO) numbers were raised at Oppenheimer. Shares are now seen reaching $30. Estimates were also increased on Alibaba IPO prospects, Oppenheimer said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Cubist Pharmaceuticals (CBST) Hits New Lifetime High

Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's New Lifetime High Stock

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Jim Cramer on the Markets: Some Stocks You Just Can't Ignore

Cubist Pharmaceuticals (CBST): Today's Pre-Market Leader Stock